Pro-Dex Revenue Jumps 16% in Fiscal Q4

Pro-Dex (NASDAQ:PDEX) reported Q4 FY2025 revenue growth of 16% to $17.5 million, driven by its top customers, but significant profitability challenges emerged as gross margin contracted sharply to 20% from 27% due to unfavorable product mix and new tariff costs. This led to a decline in net income to $1.2 million and diluted EPS to $0.36. While the company cited a record $50.4 million order backlog supporting future revenue growth expectations, investors should closely monitor ongoing margin recovery, the substantial customer concentration risk (75% from one customer), and working capital management, given the recent decrease in cash balances.

Analysis

Pro-Dex (PDEX) reported a dichotomous Q4 FY2025, with strong top-line growth undermined by significant profitability pressures. Revenue increased 16.7% year-over-year to $17.5 million, driven by increased shipments to its largest customers. However, this growth was overshadowed by a severe contraction in gross margin from 27% to 20%, attributed to a less favorable product mix and new tariff costs. Consequently, operating income fell 43.5% to $1.3 million and net income declined 25% to $1.2 million, with diluted EPS dropping to $0.36 from $0.46. The company's revenue base is extremely concentrated, with its top customer accounting for 75% of full-year sales and the top three representing 94%, presenting a material structural risk. While management highlighted a record order backlog of $50.4 million as supportive of future growth, it provided no specific financial guidance for FY2026. This forward-looking optimism is further tempered by a sharp decrease in cash balances, which were absorbed by increased inventory and accounts receivable, indicating potential working capital strain.

Key Decisions for Investors

• Given the severe customer concentration and a 700-basis-point drop in Q4 gross margin, investors should exercise caution and monitor for any signs of customer diversification or margin stabilization in the coming quarters.
• The record $50.4 million backlog provides visibility on future revenue, but the lack of specific earnings guidance requires investors to weigh this top-line potential against the clear risk of continued profit compression from tariffs and product mix.
• Scrutinize upcoming balance sheets for improvements in working capital, as the sharp Q4 decrease in cash tied to rising inventory and receivables could signal liquidity pressure if not reversed by stronger profitability or better cash conversion.